Joined Today: 14

AVNR AVANIR Pharmaceuticals, Stock Message Board

All Messages

AVNR Message Board Home | Join The AVNR Group |

#26: AVNR News Avanir Pharmaceuticals Provides Business Update and Announces Restructuring Plan
NewsBot	March 29, 2007 05:30:00 AM
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Avanir Pharmaceuticals (NASDAQ: AVNR) today provided updates on its two license and collaboration agreements and announced certain restructuring... view message ignore post recommend post

#25: AVNR News AVANIR Pharmaceuticals Appoints New Chief Executive Officer
NewsBot	March 14, 2007 05:30:00 AM
ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) today announced that Keith A. Katkin has been appointed President and CEO and elected as a member of the board... view message ignore post recommend post

#24: AVNR News AVANIR Pharmaceuticals Summarizes Outcome of FDA Meeting on Zenvia NDA
NewsBot	February 28, 2007 04:30:00 AM
ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) today announced the Company has met with U.S. Food and Drug Administration (FDA) officials to address concerns... view message ignore post recommend post

#23: AVNR News AVANIR Pharmaceuticals Announces Conference Call to Provide Zenvia FDA Meeting Update
NewsBot	February 27, 2007 05:00:00 AM
ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) today announced that management will provide an update on its meeting with the U.S. Food and Drug... view message ignore post recommend post

#22: AVNR News AVANIR Pharmaceuticals Hires Martin J. Sturgeon as Vice President and Chief Accounting Officer
NewsBot	February 12, 2007 01:10:00 PM
ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) today announced that Martin J. Sturgeon has joined the Company as Vice President and Chief Accounting Officer... view message ignore post recommend post

#21: AVNR News AVANIR Pharmaceuticals Invites Investors to Its First Quarter Conference Call on Friday, February 9, 2007
NewsBot	January 16, 2007 01:10:00 PM
ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) will webcast its quarterly conference call on Friday, February 9, 2007, at 8:00 a.m. Pacific/11:00 a.m.... view message ignore post recommend post

#20: AVNR News AVANIR Pharmaceuticals Reports Fourth Quarter Fiscal 2006 Financial Results
NewsBot	December 11, 2006 05:00:00 AM
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) today reported unaudited financial results for the quarter and fiscal year ended September 30, 2006. Fourth... view message ignore post recommend post

#19: AVNR News AVANIR Announces It Has Been Selected for Addition to the NASDAQ Biotechnology Index
NewsBot	November 16, 2006 01:15:00 PM
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ: AVNR) announced today that the Company has been selected for addition to the NASDAQ Biotechnology Index, which will be... view message ignore post recommend post

#18: AVNR News AVANIR Pharmaceuticals Invites Investors to Listen to the Lazard Capital Markets 3rd Annual Life Sciences Conference Webcast
NewsBot	November 15, 2006 01:43:00 PM
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) will be presenting at Lazard Capital Markets 3rd Annual Life Sciences Conference on Tuesday, November 28, 2006 at 8:30... view message ignore post recommend post

#17: AVNR News AVANIR Announces Last Patient Enrolled in Neuropathic Pain Phase III Trial with Zenvia
NewsBot	November 14, 2006 01:05:00 PM
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) announced today that the Company has enrolled the targeted number of patients needed to assess the efficacy endpoint... view message ignore post recommend post

#16: AVNR News AVANIR Announces Cost Reduction Initiatives and Provides Update on Zenvia for IEED
NewsBot	November 9, 2006 03:00:00 PM
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) announced today that it has taken several steps intended to significantly reduce ongoing operating expenses. Effective... view message ignore post recommend post

#15: AVNR News AVANIR Completes $15 Million Sale of Common Stock
NewsBot	November 7, 2006 01:29:00 PM
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) announced that it has completed the previously announced sales of 5,263,158 shares of Class A common stock at a price... view message ignore post recommend post

#14: AVNR News AVANIR Announces $15 Million Sale of Common Stock
NewsBot	November 3, 2006 06:29:00 AM
SAN DIEGO--(BUSINESS WIRE)--Avanir Pharmaceuticals (NASDAQ:AVNR) announced that it has entered into definitive purchase agreements with institutional investors for the offering of... view message ignore post recommend post

#13: AVNR News AVANIR Pharmaceuticals Invites Investors to Its Fourth Quarter Conference Call on Monday, December 11, 2006
NewsBot	November 2, 2006 02:15:00 PM
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) will webcast its quarterly conference call on Monday, December 11, 2006 at 8:00 a.m. Pacific / 11:00 a.m. Eastern. The... view message ignore post recommend post

#12: AVNR News AVANIR Receives FDA Approvable Letter for Zenvia for the Treatment of Involuntary Emotional Expression Disorder
NewsBot	October 31, 2006 05:30:00 AM
SAN DIEGO--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ:AVNR) announced that it has received an approvable letter from the U.S. Food and Drug Administration (FDA) for Zenvia™... view message ignore post recommend post

Group Home | Login if you want to post a message